Correlation Between Viatris and Cyclerion Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viatris and Cyclerion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viatris and Cyclerion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viatris and Cyclerion Therapeutics, you can compare the effects of market volatilities on Viatris and Cyclerion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viatris with a short position of Cyclerion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viatris and Cyclerion Therapeutics.

Diversification Opportunities for Viatris and Cyclerion Therapeutics

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Viatris and Cyclerion is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Viatris and Cyclerion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclerion Therapeutics and Viatris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viatris are associated (or correlated) with Cyclerion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclerion Therapeutics has no effect on the direction of Viatris i.e., Viatris and Cyclerion Therapeutics go up and down completely randomly.

Pair Corralation between Viatris and Cyclerion Therapeutics

Given the investment horizon of 90 days Viatris is expected to generate 0.16 times more return on investment than Cyclerion Therapeutics. However, Viatris is 6.37 times less risky than Cyclerion Therapeutics. It trades about 0.19 of its potential returns per unit of risk. Cyclerion Therapeutics is currently generating about 0.02 per unit of risk. If you would invest  1,160  in Viatris on September 1, 2024 and sell it today you would earn a total of  149.00  from holding Viatris or generate 12.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Viatris  vs.  Cyclerion Therapeutics

 Performance 
       Timeline  
Viatris 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Viatris are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Viatris may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Cyclerion Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cyclerion Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, Cyclerion Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Viatris and Cyclerion Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viatris and Cyclerion Therapeutics

The main advantage of trading using opposite Viatris and Cyclerion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viatris position performs unexpectedly, Cyclerion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclerion Therapeutics will offset losses from the drop in Cyclerion Therapeutics' long position.
The idea behind Viatris and Cyclerion Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Global Correlations
Find global opportunities by holding instruments from different markets